Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.
-
Upload
janel-roberts -
Category
Documents
-
view
213 -
download
0
Transcript of Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.
![Page 1: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/1.jpg)
Test data protection
TRIPS requirements & TRIPS-plus provisions
Carlos Correa
![Page 2: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/2.jpg)
Test data
Safety – Efficacy
Empirical information obtained through the application of standard protocols
Preclinical and clinical trials
![Page 3: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/3.jpg)
Data exclusivity
During the data exclusivity period,
national drug authorities cannot use or rely on test data to register generic equivalents
![Page 4: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/4.jpg)
As long as data exclusivity lasts…
Generic manufacturers must
=> Repeat the clinical trials
=> Wait until the expiry of the data exclusivity period
![Page 5: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/5.jpg)
TRIPS Article 39.3
Members, when requiring, as a condition of approving the marketing of pharmaceutical or of agricultural chemical products which utilize new chemical entities, the submission of undisclosed test or other data, the origination of which involves a considerable effort, shall protect such data against unfair commercial use. In addition, Members shall protect such data against disclosure, except where necessary to protect the public, or unless steps are taken to ensure that the data are protected against unfair commercial use.
![Page 6: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/6.jpg)
PROTECTION OF UNDISCLOSED INFORMATION
Article 391. In the course of ensuring effective protection against unfair competition as provided in Article 10bis of the Paris Convention (1967), Members shall protect …data submitted to governments or governmental agencies in accordance withparagraph 3.
![Page 7: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/7.jpg)
USA v Argentina: WTO settlement
-Argentina kept its system based on fair competition law
- Argentina committed itself to change its law if WTO established that exclusivity was required under TRIPS
![Page 8: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/8.jpg)
Countries without data exclusivity for pharmaceuticals
-Brasil- Filipinas- Ghana- India- Indonesia- Malaysia - Pakistan- Thailand- Uruguay
![Page 9: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/9.jpg)
PatentRegistration; market entry End patent
term
Data exclusivity
Beyond patents
Registration for new indication
Data exclusivity
![Page 10: Test data protection TRIPS requirements & TRIPS-plus provisions Carlos Correa.](https://reader036.fdocuments.net/reader036/viewer/2022082818/56649ef35503460f94c05bc8/html5/thumbnails/10.jpg)
Colchicine : 3 years of data exclusivity
-Widely available as a generic drug for gout pain in the USA since the 19th century: second-line treatment for gout
-Tests with 185 patients, one week: shortened dosing regime :
- Lawsuits to remove any other versions ofcolchicine from the market
-Price increase by a factor of more than 50, from $0.09 perpill to $4.85 per pill.